PRIMARY SCLEROSING CHOLANGITIS

被引:458
作者
LEE, YM [1 ]
KAPLAN, MM [1 ]
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR,DIV GASTROENTEROL,BOSTON,MA 02111
关键词
D O I
10.1056/NEJM199504063321406
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Primary sclerosing cholangitis, a chronic cholestatic liver disease of unknown cause, is characterized by ongoing inflammation, destruction, and fibrosis of intrahepatic and extrahepatic bile ducts.1–4 Over time, bile ducts become irregularly narrowed and obliterated, and small intrahepatic ducts disappear. Focal bile-duct dilatation proximal to areas of stricture produces a characteristic beaded appearance on cholangiography.5,6 Primary sclerosing cholangitis, although only about 1 percent as common as alcoholic liver disease,7,8 is the fourth leading indication for liver transplantation in adults in the United States.9 The disease progresses silently, but relentlessly, in most patients and leads to cirrhosis, portal hypertension,. © 1995, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:924 / 933
页数:10
相关论文
共 140 条
[1]
AADLAND E, 1987, SCAND J GASTROENTERO, V22, P655, DOI 10.3109/00365528709011139
[2]
LITHOCHOLATE METABOLISM DURING CHEMOTHERAPY FOR GALLSTONE DISSOLUTION .2. ABSORPTION AND SULFATION [J].
ALLAN, RN ;
THISTLE, JL ;
HOFMANN, AF .
GUT, 1976, 17 (06) :413-419
[3]
ROLE OF S-ADENOSYL-L-METHIONINE IN THE TREATMENT OF INTRAHEPATIC CHOLESTASIS [J].
ALMASIO, P ;
BORTOLINI, M ;
PAGLIARO, L ;
COLTORTI, M .
DRUGS, 1990, 40 :111-123
[4]
PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL SERUM ALKALINE-PHOSPHATASE ACTIVITY [J].
BALASUBRAMANIAM, K ;
WIESNER, RH ;
LARUSSO, NF .
GASTROENTEROLOGY, 1988, 95 (05) :1395-1398
[5]
SCLEROSING CHOLANGITIS - ITS POSSIBLE ASSOCIATION WITH RIEDELS STRUMA AND FIBROUS RETROPERITONITIS - REPORT OF 2 CASES [J].
BARTHOLOMEW, LG ;
CAIN, JC ;
FERRIS, DO ;
UTZ, DC ;
WOOLNER, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 1963, 269 (01) :8-&
[6]
INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE-DUCT SYNDROME IN HUMAN-LIVER ALLOGRAFTS [J].
BATTS, KP ;
MOORE, SB ;
PERKINS, JD ;
WIESNER, RH ;
GRAMBSCH, PM ;
KROM, RAF .
TRANSPLANTATION, 1988, 45 (02) :376-379
[7]
A CONTROLLED TRIAL OF NALOXONE INFUSIONS FOR THE PRURITUS OF CHRONIC CHOLESTASIS [J].
BERGASA, NV ;
TALBOT, TL ;
ALLING, DW ;
SCHMITT, JM ;
WALKER, EC ;
BAKER, BL ;
KORENMAN, JC ;
PARK, Y ;
HOOFNAGLE, JH ;
JONES, EA .
GASTROENTEROLOGY, 1992, 102 (02) :544-549
[8]
URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J].
BEUERS, U ;
SPENGLER, U ;
KRUIS, W ;
AYDEMIR, U ;
WIEBECKE, B ;
HELDWEIN, W ;
WEINZIERL, M ;
PAPE, GR ;
SAUERBRUCH, T ;
PAUMGARTNER, G .
HEPATOLOGY, 1992, 16 (03) :707-714
[9]
PHENOBARBITAL EFFECTS IN CHOLESTATIC LIVER-DISEASE [J].
BLOOMER, JR ;
BOYER, JL .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (03) :310-317
[10]
BODEN RW, 1959, LANCET, V2, P245